Evidence map›Paper›PMID 21666704›Full record

ArticleActa pharmacologica Sinica2011

Anti-cancer effects of p21WAF1/CIP1 transcriptional activation induced by dsRNAs in human hepatocellular carcinoma cell lines.

Zhi-ming Wu, Chun Dai, Ying Huang, Cui-fang Zheng, Qiong-zhu Dong, Guan Wang, Xiao-wen Li, Xiao-fei Zhang, Bin Li, Gang Chen

Open access · bronzeAbstract read
In one paragraph

Article in Acta pharmacologica Sinica, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Zhi-ming WuDepartment of Surgery, Jinshan Hospital, Fudan University, Shanghai 200540, China.
Chun Dai
Ying Huang
Cui-fang Zheng
Qiong-zhu Dong
Guan Wang
Xiao-wen Li
Xiao-fei Zhang
Bin Li
Gang Chen
Fudan University · CNChildren's Hospital of Fudan University · CNJinshan Hospital of Fudan University · CNZhongshan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate the anti-cancer effects of p21WAF1/CIP1 transcriptional activation induced by dsRNAs in hepatocellular carcinoma (HCC) cell lines.

methodsHCC cell lines BEL7402, SMMC-7721, MHCC97L, MHCC97H, and MHCCLM3 were used. HCC cells were treated with dsP21-322 (50 nmol/L), dsControl (50 nmol/L), siP21 (50 nmol/L), or mock transfection. The expression of p21 was detected using quantitative PCR and Western blot. The effects of RNA activation on HCC cells were determined using cell viability assays, apoptosis analyses and clonogenic survival assays. Western blot was also conducted to detect the expression of Bcl-xL, survivin, cleaved caspase-3, cleaved caspase-9 and cleaved PARP.

resultsAt 72 to 120 h following the transfection, dsP21-322 markedly inhibited the viability of HCC cells and clone formation. At the same times, dsP21-322 caused a significant increase in HCC cell apoptosis, as demonstrated with cytometric analysis. The phenomena were correlated with decreased expression levels of the anti-apoptotic proteins Bcl-xL, surviving, and increased expression of cleaved caspase-3, cleaved caspase-9 and cleaved PARP.

conclusionRNA-induced activation of p21 gene expression may have significant therapeutic potential for the treatment of hepatocellular carcinoma and other cancers.

Indexed as

Transcriptional ActivationApoptosisApoptosis Regulatory ProteinsCarcinoma, HepatocellularCaspase 3Caspase 9Cell Line, TumorCell SurvivalCyclin-Dependent Kinase Inhibitor p21Gene Expression Regulation, NeoplasticHumansLiver NeoplasmsRNA, Double-StrandedTransfectionApoptosis Regulatory ProteinsCaspase 3Caspase 9CDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21RNA, Double-Stranded

Identifiers

PMID21666704
PMCPMC4003122
OpenAlexW1969788959

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.